NeuroScientific Biopharmaceuticals

(ASX) NSB

Current PriceA$0.07

Market CapA$26.89M

Since IPO (2018)-69%

5 Year-78%

1 Year+5%

1 Month-34%

NeuroScientific Biopharmaceuticals Financials at a Glance

Market Cap

A$26.89M

Revenue (TTM)

A$2.21M

Net Income (TTM)

-A$1.99M

EPS (TTM)

-A$0.02

P/E Ratio

-4.54

Dividend

A$0.00

Beta (Volatility)

0.35 (Low)

Dividend

A$0.00

Beta (Volatility)

0.35 (Low)

Price

A$0.07

Volume

795,412

Open

A$0.06

Price

A$0.07

Volume

795,412

Open

A$0.06

Previous Close

A$0.07

Daily Range

A$0.06 - A$0.08

52-Week Range

A$0.06 - A$0.26

Estimated Earnings Date

Feb 24, 2026

Dividend

A$0.00

Beta (Volatility)

0.35 (Low)

Price

A$0.07

Volume

795,412

Open

A$0.06

Previous Close

A$0.07

Daily Range

A$0.06 - A$0.08

52-Week Range

A$0.06 - A$0.26

Estimated Earnings Date

Feb 24, 2026

NSB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NeuroScientific Biopharmaceuticals

Industry

Biotechnology

Sector

Health Care

CEO

Stephen Carter

Website

www.neuroscientific.com

Headquarters

Cottesloe, WA 6011, AU

NSB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-30%

Return on Capital

-22%

Return on Assets

-19%

Earnings Yield

-22.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$26.89M

Shares Outstanding

389.72M

Volume

795.41K

Avg. Volume

394.10K

Financials (TTM)

Gross Profit

-A$92.78K

Operating Income

-A$1.92M

EBITDA

-A$1.92M

Operating Cash Flow

-A$941.33K

Capital Expenditure

A$0.00

Free Cash Flow

-A$941.33K

Cash & ST Invst.

A$7.27M

Total Debt

A$0.00

NeuroScientific Biopharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

N/A

Gross Profit

-A$622.76K

-1367.7%

Gross Margin

0.00%

N/A

Market Cap

A$26.89M

N/A

Market Cap/Employee

A$2.99M

N/A

Employees

N/A

Net Income

-A$1.70M

-38.2%

EBITDA

-A$1.51M

-27.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$6.36M

+90.5%

Total Debt

A$0.00

N/A

Accounts Receivable

A$116.17K

+213.0%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

-19.07%

N/A

Return on Invested Capital

-22.45%

N/A

Free Cash Flow

-A$480.55K

-130.3%

Operating Cash Flow

-A$480.55K

-130.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NOX.AXNoxopharm Limited

NOX.AXNoxopharm LimitedA$0.08-3.75%

PIQ.AXProteomics International Laboratories Limited

PIQ.AXProteomics International Laboratories LimitedA$0.13+0.00%

NXS.AXNext Science Limited

NXS.AXNext Science LimitedA$0.15+0.00%

DOC.AXDoctor Care Anywhere Group PLC

DOC.AXDoctor Care Anywhere Group PLCA$0.12+0.00%

RAD.AXRadiopharm Theranostics Limited

RAD.AXRadiopharm Theranostics LimitedA$0.02+5.26%

ATX.AXAmplia Therapeutics Limited

ATX.AXAmplia Therapeutics LimitedA$0.11+0.00%

CYP.AXCynata Therapeutics Limited

CYP.AXCynata Therapeutics LimitedA$0.26+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

NOKNokia

NOKNokia$14.80+0.05%

NVDANvidia

NVDANvidia$205.19+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About NSB

What is the current price of NeuroScientific Biopharmaceuticals?

NeuroScientific Biopharmaceuticals is trading at A$0.07 per share.

What is the 52-week range for NeuroScientific Biopharmaceuticals?

Over the past 52 weeks, NeuroScientific Biopharmaceuticals has traded between A$0.06 and A$0.26.

How much debt does NeuroScientific Biopharmaceuticals have?

As of the most recent reporting period, NeuroScientific Biopharmaceuticals reported total debt of A$0.00.

How much cash does NeuroScientific Biopharmaceuticals have on hand?

NeuroScientific Biopharmaceuticals reported A$7.27M in cash and cash equivalents in its most recent financial results.

What is NeuroScientific Biopharmaceuticals’s dividend yield?

NeuroScientific Biopharmaceuticals does not currently have a dividend yield.

NeuroScientific Biopharmaceuticals

NeuroScientific Biopharmaceuticals Financials at a Glance

NSB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About NeuroScientific Biopharmaceuticals

NSB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

NeuroScientific Biopharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NSB

What is the current price of NeuroScientific Biopharmaceuticals?

What is the 52-week range for NeuroScientific Biopharmaceuticals?

How much debt does NeuroScientific Biopharmaceuticals have?

How much cash does NeuroScientific Biopharmaceuticals have on hand?

What is NeuroScientific Biopharmaceuticals’s dividend yield?

Premium Investing Services